Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Lefelsiran sodium by Novo Nordisk for Alcohol Dependence: Likelihood of Approval
Lefelsiran sodium is under clinical development by Novo Nordisk and currently in Phase I for Alcohol Dependence. According to GlobalData,...